期刊文献+

Ubc9在肺癌组织中的表达及意义 被引量:1

Expression and significance of Ubc9 in lung cancer
下载PDF
导出
摘要 目的:探讨Ubc9在人肺癌组织中的表达及临床意义。方法:应用免疫组织化学法和实时荧光定量PCR(real time quantitative PCR,RT-qPCR)法检测143例肺癌组织及同源非癌变组织中Ubc9的表达情况,并对临床病理资料进行分析。结果:与癌旁组织相比,Ubc9在肺癌组织中呈高表达(P<0.05),Ubc9的表达与年龄、淋巴结转移、TNM分期及预后密切相关,有统计学意义(P<0.05);而与性别、病理学类型、组织分化程度无关。结论:小细胞肺癌、肺鳞癌和肺腺癌中均有Ubc9阳性表达,均高于正常的肺组织,并且与肺癌淋巴结转移程度相关,提示Ubc9可能与肺癌细胞的转移特性有关。 Objective:To investigate the expressions and clinical significance of Ubc9 in human lung cancer and its prognostic significance. Methods:The expression of Ubc9 in 143 lung cancer specimens and adjacent normal tis-sues were detected by immunohistochemical( IHC)and real time quantitative PCR method. The relationship between the Ubc9 expression and pathological data,prognostic factors were analyzed. Results:Compared with adjacent normal tissues,the expression of Ubc9 mRNA in cancerous tissues was higher(P〈0. 05). The expression of Ubc9 was statis-tically significantly correlated with age,lymph nodes metastasis,clinical stage and prognosis(P〈0. 05),but was not correlated with sex,histological type,differential(P〉0. 05). Conclusion:The high expressions of Ubc9 in lung canc-er was related to lymph nodes metastasis,and may be associated with the metastasis of lung cancer.
出处 《现代肿瘤医学》 CAS 2014年第10期2343-2346,共4页 Journal of Modern Oncology
基金 辽宁省博士科研启动基金计划资助项目(编号:20141036)
关键词 UBC9 肺癌 转移 Ubc9 lung cancer metastasis
  • 相关文献

参考文献2

二级参考文献39

  • 1Sakata S, Fujiwara M, Ohtsuka K, et al. AlP-binding cassette transporters in primary central nervous system lyrnphorna: decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells [J]. Oncol Rep, 2011,25(2):333-339.
  • 2Berge EO, Knappskog S, Geisler S, et at. Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers [J]. Mol Cancer, 2010(9) 173.
  • 3Johnson KA, Brown PH. Drug development for cancer chemoprevention: focus on molecular targets [J] Semin Oncol, 2010,37(4):345-358.
  • 4Moschos S J, Smith AP,MandicM, et al. SAGE and anlibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced stage melanomas [J]. Oncogene, 2007,26(29):4216-4225.
  • 5Deng H, Lin Y, Badin M, et al. Over-accumulation of nuclear IGF-1 receptor in tumor cells requires elevated expression ol the receptor and the SUMQ-conjugating enzyme Ubc9 [J] Biochem Biophys Res Commun, 2011,404(2):667 671.
  • 6Yu F, Deng H, Yao H, et al. Mir-30 reduction mainlains sell renewal and inhibits apoptosis in breast tumor-initiating cells [J]. Oncogene. 2010,29(29):4194-4204.
  • 7Mo Y, Yu Y, Theodosiou E, et al. A role for Ube9 in tumorigenesis [J]. Oncogene, 2005,24(16):2677-2683.
  • 8Kalashnikova EV, Revenko AS, Gemo AT, et al. ANCCA/AIAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple negative cells through control of B-Myb arid EZH2 [J]. Cancer Res, 2010,70(22):9402-9412.
  • 9Soltysova A, Altanerova V, Altaner C. Cancer stum cells[J]. Neoplasma, 2005,52(6):435-440.
  • 10Longley DB, Johnston PG. Molecular mechanisms of drug resistance [J]. J Pathol, 2005,205(2):275-292.

共引文献100

同被引文献13

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部